Clinical Trial Update: CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CD34-selected allogeneic hematopoietic stem cell transplantation with myeloablative conditioning plus CD8+ memory T-cell infus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CD34-selected allogeneic hematopoietic stem cell transplantation
• CD8+ memory T-cell infusion (CD8+ memory T cells)

Snippet

Sponsor: Robert Lowsky | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2024-10-17